We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TER:NASDAQTeradyne, Inc. Analysis

Data as of 2026-03-10 - not real-time

$296.44

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Teradyne (TER) is riding a wave of AI‑driven semiconductor test demand, as recent earnings showed a 44% YoY revenue jump and net income rising 2.2% to $554 million. The company’s gross margin of 58% and operating margin of 30% underscore its pricing power, while forward EPS is projected at $8.11 versus trailing $3.47, indicating rapid earnings acceleration. However, the stock trades at a trailing P/E of 85×—far above the industry average of 37×—and a DCF‑derived fair value of roughly $66, suggesting the market has priced in a substantial premium. Technical signals are mixed: the price sits above the 50‑day SMA (264) and 200‑day SMA (162) in a bullish trend, but below the 20‑day SMA (314) and with a bearish MACD histogram, while volatility is extremely high at 78% and beta approaches 2.0. Volume is increasing, and sentiment is buoyant (Fear‑Greed Index at “Extreme Greed”). The dividend is modest (0.18% yield) with a low payout ratio (13.8%), and cash flow remains positive despite a high debt‑to‑equity ratio of over 10.
Given the strong top‑line growth, solid profitability, and AI tailwinds, the upside potential is limited by the current overvaluation and elevated risk profile. Investors should weigh the short‑term momentum against the long‑term valuation correction risk.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Recent earnings beat and 44% revenue growth driven by AI chip testing
  • Increasing trading volume supporting momentum
  • Support level around $263 provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong forward EPS outlook and expanding margins
  • Sustained demand from AI and semiconductor sectors
  • Robust cash flow despite high leverage

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Long‑term secular growth in semiconductor test equipment
  • Potential valuation correction from current overpricing
  • High volatility and beta increase price risk over extended horizons

Key Metrics & Analysis

Financial Health

Revenue Growth43.90%
Profit Margin17.37%
P/E Ratio85.4
ROE19.73%
ROA10.83%
Debt/Equity10.13
P/B Ratio16.6
Op. Cash Flow$674.4M
Free Cash Flow$270.6M
Industry P/E36.8

Technical Analysis

TrendBullish
RSI50.5
Support$263.02
Resistance$344.92
MA 20$313.83
MA 50$264.29
MA 200$162.43
MACDBearish
VolumeIncreasing
Fear & Greed Index77.14

Valuation

Fair Value$65.95
Target Price$307.41
Upside/Downside3.70%
GradeOvervalued
TypeGrowth
Dividend Yield0.18%

Risk Assessment

Beta1.96
Volatility78.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.